These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 19362719

  • 1. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
    Georgopoulos NA, Katsikis I, Florakis D, Panidis D, Kandarakis ED.
    Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio Paparatti U, Pasanisi F.
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [Abstract] [Full Text] [Related]

  • 7. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.
    Vosnakis C, Georgopoulos NA, Armeni AK, Papadakis E, Roupas ND, Katsikis I, Panidis D.
    Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):185-9. PubMed ID: 22579228
    [Abstract] [Full Text] [Related]

  • 8. The effect of sibutramine therapy on occurrence of depression symptoms among obese patients.
    Slovacek L, Pavlik V, Slovackova B.
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):e43-4. PubMed ID: 18676135
    [No Abstract] [Full Text] [Related]

  • 9. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K, Finer N, Rössner S.
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term medication use and weight loss maintenance: an observational study.
    Womble LG, Wadden TA, Berkowitz RI, Sarwer DB, Rothman RA.
    Obes Res; 2001 Oct; 9(10):652-3. PubMed ID: 11595785
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of weight loss on the metabolic syndrome.
    Phelan S, Wadden TA, Berkowitz RI, Sarwer DB, Womble LG, Cato RK, Rothman R.
    Int J Obes (Lond); 2007 Sep; 31(9):1442-8. PubMed ID: 17356528
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Orlistat and sibutramine beyond weight loss.
    Mannucci E, Dicembrini I, Rotella F, Rotella CM.
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [Abstract] [Full Text] [Related]

  • 19. [Weight loss lowers blood pressure, lipids and blood glucose. Sibutramine also helps diabetics with weight loss].
    MMW Fortschr Med; 2002 Sep 12; 144(37):56. PubMed ID: 12380343
    [No Abstract] [Full Text] [Related]

  • 20. Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women.
    Lazurova I, Dravecka I, Kraus V, Petrovicova J.
    Bratisl Lek Listy; 2004 Sep 12; 105(5-6):207-10. PubMed ID: 15535111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.